eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


2/2017
vol. 16
 
Share:
Share:
abstract:
Review paper

Anti-Müllerian hormone (AMH) as a good predictor of time of menopause

Aleksandra Kruszyńska
,
Jadwiga Słowińska-Srzednicka

Menopause Rev 2017; 16(2): 47-50
Online publish date: 2017/06/30
View full text Get citation
 
PlumX metrics:
Anti-Müllerian hormone (AMH) in women is secreted by granulosa cells in late preantral and small antral follicles. AMH seems to be a very stable marker having some advantages over other biochemical and biophysical markers and is very useful in the assessment of ovarian reserve. AMH measurement may be used in cases of premature ovarian failure, including iatrogenic, due to treatment for cancer, hypogonadotropic hypogonadism, and lastly, in polycystic ovary syndrome (PCOS). It is also a very specific marker of ovarian tumors – folliculomas. According to outcomes of some studies, AMH seems to be highly predictive for the timing of menopause. There are mathematical models in which a single AMH measurement is used to predict the time of menopause even in very young women, many years before the last period.
keywords:

anti-Müllerian hormone (AMH), menopause, ovarian reserve, premature ovarian failure (POF)

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.